PRI vs REGN · P/E 12, rev $788.1M vs P/E 14, rev $14.34B
Primerica Inc (PRI) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Primerica Inc (PRI) is a insurance - life company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PRI revenue for 2024-12-31 was $788.1M. Net income was $167.1M. Revenue was up 1.8% from 2024-09-30 to 2024-12-31. PRI currently screens at market cap $8.82B and trailing P/E 12.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PRI currently screens at market cap $8.82B and trailing P/E 12.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PRI and REGN stock pages for the full models.
Not investment advice.